Gene · 7791
Papers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,771
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling. | Nat Commun | 2023 | 37322019 | PubTator, text mining | PubMed |
| Repair of noise-induced damage to stereocilia F-actin cores is facilitated by XIRP2 and its novel mechanosensor domain. | Elife | 2023 | 37294664 | PubTator, text mining | PubMed |
| Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamics. | J Cell Biol | 2023 | 37278764 | PubTator, text mining | PubMed |
| Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs. | Int J Mol Sci | 2023 | 37240037 | PubTator, text mining | PubMed |
| Identification of Potential Inflammation-Related Genes and Key Pathways Associated with Complex Regional Pain Syndrome. | Biomolecules | 2023 | 37238642 | PubTator, text mining | PubMed |
| Epigenetic and Tumor Microenvironment for Prognosis of Patients with Gastric Cancer. | Biomolecules | 2023 | 37238607 | PubTator, text mining | PubMed |
| Enhancement of Zyxin Promotes Skin Fibrosis by Regulating FAK/PI3K/AKT and TGF-β Signaling Pathways via Integrins. | Int J Biol Sci | 2023 | 37215989 | PubTator, text mining | PubMed |
| Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho-ROCK-mediated contractility dependent. | Bioeng Transl Med | 2023 | 37206242 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
| FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation. | J Mammary Gland Biol Neoplasia | 2023 | 37191822 | PubTator, text mining | PubMed |
| Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma. | Cancers (Basel) | 2023 | 37190333 | PubTator, text mining | PubMed |
| Mechanistic insights into the development of severe fetal growth restriction. | Clin Sci (Lond) | 2023 | 37186255 | PubTator, text mining | PubMed |
| A Novel Hybrid Runge Kutta Optimizer with Support Vector Machine on Gene Expression Data for Cancer Classification. | Diagnostics (Basel) | 2023 | 37175012 | PubTator, text mining | PubMed |
| Theoretical and Data-Driven Approaches for Biomolecular Condensates. | Chem Rev | 2023 | 37171907 | PubTator, text mining | PubMed |
| Polychaetoid/ZO-1 strengthens cell junctions under tension while localizing differently than core adherens junction proteins. | Mol Biol Cell | 2023 | 37163320 | PubTator, text mining | PubMed |
| PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer. | J Cancer | 2023 | 37151397 | PubTator, text mining | PubMed |
| Understanding Nephrotic Syndrome Using Kidney Transcriptome Profiling and Computational Studies. | Kidney360 | 2023 | 37103957 | PubTator, text mining | PubMed |
| A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes. | Front Immunol | 2023 | 37090691 | PubTator, text mining | PubMed |
| Computational analysis of the flexibility in the disordered linker region connecting LIM domains in cysteine-glycine-rich protein. | Front Genet | 2023 | 37065494 | PubTator, text mining | PubMed |
| An Efficient Continuous Flow Synthesis for the Preparation of N-Arylhydroxylamines: Via a DMAP-Mediated Hydrogenation Process. | Molecules | 2023 | 37049731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7791/papers?page=8